National Health Investors, Inc. (NHI) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

183.59 k

Shareholding (Mar 2025)

FII

11.18%

Held by 115 FIIs

DII

54.77%

Held by 38 DIIs

Promoter

0.00%

How big is National Health Investors, Inc.?

22-Jun-2025

As of Jun 18, National Health Investors, Inc. has a market capitalization of $3.30 billion, with net sales of $345.86 million and a net profit of $139.80 million over the last four quarters.

What does National Health Investors, Inc. do?

22-Jun-2025

National Health Investors, Inc. is a self-managed REIT focused on financing senior housing and medical investments, with a market cap of approximately $3.3 billion. As of March 2025, it reported net sales of $90 million and a net profit of $34 million.

Who are in the management team of National Health Investors, Inc.?

22-Jun-2025

As of March 2022, the management team of National Health Investors, Inc. includes Independent Chairman Mr. W. Andrew Adams and Independent Directors Mr. James Jobe, Mr. Robert McCabe, and Mr. Robert Webb.

Is National Health Investors, Inc. overvalued or undervalued?

20-Sep-2025

As of August 27, 2025, National Health Investors, Inc. is considered very attractive due to its undervalued status reflected in a P/E ratio of 23, a competitive EV to EBITDA ratio of 12.07, a solid ROCE of 14.97%, and a high dividend yield of 461.57%, despite recent underperformance compared to the S&P 500.

Is National Health Investors, Inc. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, National Health Investors, Inc. shows a bullish technical trend supported by strong weekly indicators, despite mixed monthly signals, with a one-month return of 5.80% compared to the S&P 500's 2.33%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 9.57%

Poor long term growth as Operating profit has grown by an annual rate of -3.24%

Flat results in Jun 25

With ROE of 10.44%, it has a fair valuation with a 2.37 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Realty

Market cap

USD 3,727 Million (Small Cap)

P/E

23.00

Industry P/E

Dividend Yield

419.29%

Debt Equity

-999,999.00

Return on Equity

10.17%

Price to Book

2.52

Revenue and Profits:

Net Sales:

91 Million

(Quarterly Results - Jun 2025)

Net Profit:

37 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

2.36%

6 Months

11.28%

1 Year

4.58%

2 Years

41.4%

3 Years

38.76%

4 Years

47.85%

5 Years

18.86%

National Health Investors, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is National Health Investors, Inc. technically bullish or bearish?

As of 8 September 2025, the technical trend for National Health Investors, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supporting the positive trend, while the monthly MACD is mildly bearish, indicating some caution. The weekly RSI is bearish, but the daily moving averages are bullish, reinforcing the overall bullish stance. Bollinger Bands are bullish on both weekly and monthly time frames. The KST is bullish weekly but mildly bearish monthly, and Dow Theory shows a mildly bullish stance on both time frames. In terms of performance, the stock has returned 5.80% over the past month compared to 2.33% for the S&P 500, and it has a year-to-date return of 14.33% versus 12.22% for the benchmark. However, the one-year return is negative at -6.95%, while the S&P 500 has gained 17.14%. Overall, the current technical stance is bullish, driven by strong weekly indicators despite som...

Is National Health Investors, Inc. overvalued or undervalued?

As of 27 August 2025, the valuation grade for National Health Investors, Inc. has moved from attractive to very attractive, indicating a strong positive shift in its valuation outlook. The company appears to be undervalued, particularly when considering its P/E ratio of 23, which is lower than the peer average of approximately 24.77, and an EV to EBITDA ratio of 12.07, also competitive against peers like Broadstone Net Lease, Inc. at 9.17. Additionally, the PEG ratio of 4.40 suggests that while growth expectations may be high, the current price does not fully reflect the potential growth of the company. In comparison to its peers, National Health Investors, Inc. stands out with a solid ROCE of 14.97% and a dividend yield of 461.57%, which is significantly attractive in the current market. Notably, while the company has underperformed the S&P 500 over the past year with a return of -6.95% compared to 17.14%...

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1.42%

EBIT Growth (5y)

-3.24%

EBIT to Interest (avg)

5.22

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

115.16%

Pledged Shares

Institutional Holding

74.42%

ROCE (avg)

13.88%

ROE (avg)

9.57%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.37

EV to EBIT

16.81

EV to EBITDA

12.07

EV to Capital Employed

2.52

EV to Sales

9.40

PEG Ratio

4.40

Dividend Yield

461.57%

ROCE (Latest)

14.97%

ROE (Latest)

10.44%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 66 Schemes (33.98%)

Foreign Institutions

Held by 115 Foreign Institutions (11.18%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.56% vs 4.05% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 8.58% vs -21.03% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91.40",
          "val2": "90.00",
          "chgp": "1.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "71.70",
          "val2": "69.20",
          "chgp": "3.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.00",
          "val2": "14.30",
          "chgp": "4.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.00",
          "val2": "-1.70",
          "chgp": "41.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "36.70",
          "val2": "33.80",
          "chgp": "8.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "558.80%",
          "val2": "547.70%",
          "chgp": "1.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.87% vs 12.85% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.64% vs 105.19% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "338.10",
          "val2": "322.40",
          "chgp": "4.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "263.90",
          "val2": "251.50",
          "chgp": "4.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "59.90",
          "val2": "58.20",
          "chgp": "2.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.30",
          "val2": "-1.90",
          "chgp": "-231.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "136.60",
          "val2": "134.40",
          "chgp": "1.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "560.70%",
          "val2": "555.30%",
          "chgp": "0.54%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

91.40

90.00

1.56%

Operating Profit (PBDIT) excl Other Income

71.70

69.20

3.61%

Interest

15.00

14.30

4.90%

Exceptional Items

-1.00

-1.70

41.18%

Consolidate Net Profit

36.70

33.80

8.58%

Operating Profit Margin (Excl OI)

558.80%

547.70%

1.11%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.56% vs 4.05% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 8.58% vs -21.03% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

338.10

322.40

4.87%

Operating Profit (PBDIT) excl Other Income

263.90

251.50

4.93%

Interest

59.90

58.20

2.92%

Exceptional Items

-6.30

-1.90

-231.58%

Consolidate Net Profit

136.60

134.40

1.64%

Operating Profit Margin (Excl OI)

560.70%

555.30%

0.54%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 4.87% vs 12.85% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1.64% vs 105.19% in Dec 2023

All Annual Results

Company CV

About National Health Investors, Inc.

National Health Investors, Inc.

Realty

National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company is specialized in the sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. The Company manages approximately 236 properties in over 34 states. The senior housing in its portfolio are either need-driven or discretionary for end users and consist of independent living facilities, assisted living facilities, senior living campuses, and entrance-fee communities. The medical facilities within its portfolio consist of skilled nursing facilities, hospitals and medical office buildings.

Company Coordinates

Company Details

222 Robert Rose Dr , MURFREESBORO TN : 37129-6346

Tel: 1 615 8909100

http://www.nhireit.com

Registrar Details

National Health Investors, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is National Health Investors, Inc.?

Watch in Real-Time

What does National Health Investors, Inc. do?

Who are in the management team of National Health Investors, Inc.?

Is National Health Investors, Inc. overvalued or undervalued?

Is National Health Investors, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 9.57%

Poor long term growth as Operating profit has grown by an annual rate of -3.24%

Flat results in Jun 25

With ROE of 10.44%, it has a fair valuation with a 2.37 Price to Book Value

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is National Health Investors, Inc. technically bullish or bearish?

Is National Health Investors, Inc. overvalued or undervalued?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About National Health Investors, Inc.

Company Coordinates